Blog Post Discusses Zika Vaccine Research, Importance Of ‘Leveraging’ Research On Other Diseases

BioMed Central’s “On Health”: When will we get to a Zika vaccine: hints from dengue research on protective immunity
Meng Ling Moi, an associate professor at the Institute of Tropical Medicine, Nagasaki University, discusses Zika vaccine research, noting “the vaccination strategy for Zika may be less complicated in comparison to dengue,” and the importance of leveraging research on dengue, Japanese Encephalitis, and other flavivirus diseases, in order to understand Zika (3/15).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

The Henry J. Kaiser Family Foundation Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KaiserFamilyFoundation | twitter.com/kff

Filling the need for trusted information on national health issues, the Kaiser Family Foundation is a nonprofit organization based in San Francisco, California.